Geisinger's Oncology Pharmacy Residency is a specialized program consisting of 12 months of individualized training designed to provide a diverse clinical experience which focuses on direct patient care in a wide variety of settings.
Program goal: To cultivate the clinical knowledge, skills, attitudes and leadership capabilities necessary to train clinical experts in patient-centered hematology/oncology pharmacy practice.
Pharmacists completing the PGY2 Oncology Pharmacy Residency program at Geisinger Medical Center will become competent and confident clinical experts in patient-centered hematology/oncology pharmacy practice. Residents will gain experience through variety of inpatient and outpatient practice sites for adult hematology, oncology and stem cell transplant patients, as well as inpatient pediatric hematology/oncology. Longitudinal experiences are designed to develop and refine the resident’s expertise to include: leadership, mediation safety, informatics, research, medical writing and medical education/preceptorship. Graduates from the program will be prepared to provide clinical pharmacy services for oncology, hematology and stem cell transplant patient populations in both the acute and ambulatory care settings across an integrated health system.
About the Geisinger Cancer Institute
The Geisinger Cancer Institute provides integral and personalized care by experienced hematologists and medical oncologists at multiple care delivery sites throughout Pennsylvania. The cancer programs at both Geisinger Medical Center (GMC) and Geisinger Wyoming Valley (GWV) are accredited by the American College of Surgeons Commission on Cancer as well as achieving QOPI® (Quality Oncology Practice Initiative) certification from the American Society of Clinical Oncology (ASCO). The bone marrow transplant program is Autologous Stem Cell Transplant accredited by the Foundation for Accreditation of Cellular Therapy (FACT). The Geisinger Cancer Institute is also an NCI-supported Community Clinical Oncology Research Program (NCORP) which is the core of the oncology clinical trials program providing a direct link to the NCI. Through the Janet Weis Children's Hospital, pediatric inpatient and outpatient services are provided to pediatric hematology and oncology patients.